AstraZeneca’s vaccine is 79 percent effective in a U.S. study and the company is preparing to apply for emergency authorization from the Food and Drug Administration. But its shot may not be needed in the United States. Orignially published in NYT.

Small Business Minder
error: Content is protected !!